DUBLIN--(BUSINESS WIRE)--Sep 3, 2018--The "Global Vitiligo Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Vitiligo Therapeutics Market to grow at a CAGR of 4.41% during the period 2018-2022.

Global Vitiligo Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the retail sales of all approved medicines, generic medicines, and off-label drugs used in the treatment of vitiligo across the globe.

According to the report, one driver influencing this market is the rising importance of aesthetic appeal. The importance of aesthetic appeal is growing significantly, especially in the emerging economies like India and China.

One trend affecting this market is the growing disposable income in emerging countries. The disposable income in the emerging economies has seen a significant increase in the recent years, which has resulted in the growth of the revenue generated from vitiligo therapeutics.

Further, the report states that one challenge affecting this market is poor patient adherence. Various factors, including the physician, patient, disease state, and medications selected, can influence adherence to drug regimens.

Key vendors

Astellas Pharma Bausch Health Baxter Mallinckrodt Puneet Laboratories

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Disease Overview

Part 05: Market Landscape

Part 06: Market Sizing 2017-2022

Part 07: Five Forces Analysis

Part 08: Pipeline

Part 09: Market Segmentation By Roa

Part 10: Customer Landscape

Part 11: Regional Landscape

Part 12: Decision Framework

Part 13: Drivers And Challenges

Part 14: Market Trends

Part 15: Vendor Landscape

Part 16: Vendor Analysis

For more information about this report, visit https://www.researchandmarkets.com/research/9zfjbp/global_vitiligo?w=4.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180903005247/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/03/2018 12:09 PM/DISC: 09/03/2018 12:09 PM